Novel Delivery Method of Transgender Voice Therapy Using a Mobile Application
1 other identifier
interventional
50
1 country
2
Brief Summary
The investigators hypothesize that the mobile application they developed for transgender and gender diverse individuals (TGGD) will be equivalent or better than traditional speech therapy in improving voice quality. The investigators will measure both how the participants feel about their voices and how their voice actually sounds to see if the app is effective.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2026
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 3, 2023
CompletedFirst Posted
Study publicly available on registry
April 18, 2023
CompletedStudy Start
First participant enrolled
December 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
Study Completion
Last participant's last visit for all outcomes
December 1, 2028
December 22, 2025
December 1, 2025
1 year
April 3, 2023
December 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change in Transsexual Voice Questionnaire (TVQ) Scores
The Transsexual Voice Questionnaire (TVQ) is a 30-item questionnaire that assesses self-perception of voice in transgender individuals. Responses range from (1) rarely or never to (4) usually or always. Scores range from 30 (no perceived voice difficulty) to 120 (high perceived voice difficulty).
Baseline, Week 4, Week 11
Change in Transgender Self Evaluation Questionnaire (TSEQ) Scores
The Transgender Self Evaluation Questionnaire (TSEQ) is a 30-item questionnaire that assesses self perception in transgender and gender diverse individuals. Responses range from (1) never (4) always. Scores range from 30 (low voice satisfaction) to 120 (high voice satisfaction)
Baseline, Week 4, Week 11
Change in Fundamental Frequency
The acoustic measure fundamental frequency will be obtained by analyzing participant's voice recordings via multi-speech acoustic analyses program of Kay-Pentax
Baseline, Week 4, Week 11
Change in Formants
The acoustic measure formants will be obtained by analyzing participant's voice recordings via multi-speech acoustic analyses program of Kay-Pentax
Baseline, Week 4, Week 11
Secondary Outcomes (1)
Usability of Mobile Application as measured by the Mobile Application Rating Scale (MARS)
Week 11
Study Arms (2)
Transgender and gender diverse (TGGD) individuals using the pilot app
EXPERIMENTALThe investigators will develop Attuned, an open access voice and communication modification training (VCMT) app based on standard of care. Participants will undergo VCMT via the mobile application, Attuned. Participants will include healthy transgender and gender diverse (TGGD) individuals seeking voice modification to better reflect their identity.
Transgender and gender diverse (TGGD) individuals receiving standard voice modification
ACTIVE COMPARATORVCMT via speech pathology will be compared to the efficacy of an app-based VCMT program. Participants will undergo VCMT in-person. Participants will include healthy transgender and gender diverse (TGGD) individuals seeking voice modification to better reflect their identity.
Interventions
Subjects will undergo voice and communication modification therapy via the Attuned application. This consists of an 11 week program consisting of different modules to learn how to modify voice (e.g., pitch, intonation, resonance). At the end of each module, participants will be given exercises to practice what they learned.
Subjects will undergo standard of care in-person voice modification therapy at Ithaca College.
Eligibility Criteria
You may qualify if:
- Identify as a transgender individual
- Be 18 years or older
- Be able to read and write in English
- Have an iOS or Android Device
You may not qualify if:
- Identify as cisgender
- Experience hoarseness
- Experiencing any physical pain related to voice use
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Weill Medical College of Cornell Universitylead
- Ithaca Collegecollaborator
Study Sites (2)
Ithaca College
Ithaca, New York, 14850, United States
Weill Cornell Medicine
New York, New York, 10022, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Anaïs Rameau, MD
Weill Medical College of Cornell University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 3, 2023
First Posted
April 18, 2023
Study Start (Estimated)
December 1, 2026
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2028
Last Updated
December 22, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share